![Jay Stout](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jay Stout
Chief Tech/Sci/R&D Officer at
IMMUNOVANT, INC.
Net worth: 7 M $ as of 31/05/2026
Profile
Jay S.
Stout is Chief Technology Officer at Immunovant, Inc. since 2023.
Formerly, Dr. Stout was Chief Technical Officer at Immunomedics, Inc. and Senior Vice President-Technical Operations at Versartis, Inc. Education includes undergraduate and graduate degrees from the University of Iowa and a doctorate from The University of Nebraska-Lincoln.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
IMMUNOVANT INC 0.1% | 26/06/2026 | 211,685 ( 0.1% ) | 7 M $ | 31/05/2026 |
Jay Stout active positions
| Companies | Position | Start |
|---|---|---|
| IMMUNOVANT, INC. | Chief Tech/Sci/R&D Officer | 01/04/2023 |
Former positions of Jay Stout
| Companies | Position | End |
|---|---|---|
| IMMUNOMEDICS, INC. | Chief Tech/Sci/R&D Officer | - |
Versartis, Inc.
 Versartis, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic proteins for the treatment of metabolic diseases and endocrine disorders | Chief Tech/Sci/R&D Officer | - |
Training of Jay Stout
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
8
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Develops drugs for the treatment of cancer | Health Technology |
University of Iowa
 University of Iowa Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic proteins for the treatment of metabolic diseases and endocrine disorders | Health Technology |
The University of Nebraska-Lincoln
 The University of Nebraska-Lincoln Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immunovant, Inc.
 Immunovant, Inc. BiotechnologyHealth Technology Develops restorative therapies for autoimmune diseases | Health Technology |
- Stock Market
- Insiders
- Jay Stout
